3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
12
Breast Neoplasms
12
Pain
11
Neoplasms
10
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
6
Agnosia
6
Colonic Neoplasms
5
Neuralgia
4
Keratosis, Actinic
4
Cancer Pain
4
Liver Neoplasms
3
Leiomyoma
3
Head and Neck Neoplasms
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Tea
2
Bupivacaine
2
Tadalafil
1
Supine Position
1
Morphine
1
Lidocaine
1
Ketamine
1
Injections, Subcutaneous
1
Influenza Vaccines
1
Head-Down Tilt
1
Ethanol
1
Dexmedetomidine
1
Anesthetics, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Abdominal Cancer
×
Lidocaine
×
Clear all
NCT03063112
2017-02-28
RF
South Egypt Cancer Institute
Phase NA
Unknown
79 enrolled